Master_of_Fine_Charts

XERS- A little consolidation before take off

Long
NASDAQ:XERS   Xeris Biopharma Holdings, Inc.
After bottoming out in early December at the 200 sma it has made higher lows and the 9ema crossed the 20 ema. In addition both EMAs crossed the 50 sma showing us that the short and medium term trends are bullish. This will bounce around a bit in the $5.70-$5.09 range as it builds a new base before moving to new highs. It will see some resistance at $6.33

First target $7.16
Second target $7.68
Third target $8.68
Final Destination $11.60

I am long XERS and consider it a buy and add for 2021

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.